Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.5771
-0.0401 (-6.50%)
At close: May 30, 2025, 4:00 PM
0.6100
+0.0329 (5.70%)
After-hours: May 30, 2025, 7:19 PM EDT

Context Therapeutics Stock Forecast

CNTX's stock price has decreased by -71.15% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Context Therapeutics stock ranges from a low of $4.00 to a high of $9.00. The average analyst price target of $6.00 forecasts a 939.68% increase in the stock price over the next year.

Price Target: $6.00 (+939.68%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $6.00 $5.00 $9.00
Change +593.12% +939.68% +766.40% +1459.5%

Analyst Ratings

The average analyst rating for Context Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 333332
Buy 122232
Hold 000000
Sell 000000
Strong Sell 000000
Total 455564

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,459.52% May 8, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,459.52% Apr 29, 2025
William Blair
William Blair
Buy
Initiates
n/a
Buy Initiates n/a n/a Apr 21, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong Buy Maintains $9 +1,459.52% Apr 9, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +766.40% Mar 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 45.36M
Revenue Next Year
n/a
EPS This Year
-0.27
from -0.46
EPS Next Year
-0.33
from -0.27
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
---9.25M45.36M
Revenue Growth
----390.65%---
EPS
-3.96-3.69-0.93-1.50-0.46-0.27-0.33-0.38
EPS Growth
--------
Forward PE
--------
No. Analysts
-----888
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -0.23 -0.29 -0.33
Avg -0.27 -0.33 -0.38
Low -0.35 -0.37 -0.43

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.